Open Access

The reliability of the physical examination to guide fluid therapy in adults with severe falciparum malaria: an observational study

  • Josh Hanson1, 2Email author,
  • Sophia WK Lam1,
  • Shamsul Alam3,
  • Rajyabardhan Pattnaik4,
  • Kishore C Mahanta4,
  • Mahatab Uddin Hasan3,
  • Sanjib Mohanty4,
  • Saroj Mishra4,
  • Sophie Cohen5,
  • Nicholas Day1, 6,
  • Nicholas White1, 6 and
  • Arjen Dondorp1, 6
Malaria Journal201312:348

https://doi.org/10.1186/1475-2875-12-348

Received: 5 August 2013

Accepted: 20 September 2013

Published: 1 October 2013

Abstract

Background

Adults with severe malaria frequently require intravenous fluid therapy to restore their circulating volume. However, fluid must be delivered judiciously as both under- and over-hydration increase the risk of complications and, potentially, death. As most patients will be cared for in a resource-poor setting, management guidelines necessarily recommend that physical examination should guide fluid resuscitation. However, the reliability of this strategy is uncertain.

Methods

To determine the ability of physical examination to identify hypovolaemia, volume responsiveness, and pulmonary oedema, clinical signs and invasive measures of volume status were collected independently during an observational study of 28 adults with severe malaria.

Results

The physical examination defined volume status poorly. Jugular venous pressure (JVP) did not correlate with intravascular volume as determined by global end diastolic volume index (GEDVI; rs = 0.07, p = 0.19), neither did dry mucous membranes (p = 0.85), or dry axillae (p = 0.09). GEDVI was actually higher in patients with decreased tissue turgor (p < 0.001). Poor capillary return correlated with GEDVI, but was present infrequently (7% of observations) and, therefore, insensitive. Mean arterial pressure (MAP) correlated with GEDVI (rs = 0.16, p = 0.002), but even before resuscitation patients with a low GEDVI had a preserved MAP. Anuria on admission was unrelated to GEDVI and although liberal fluid resuscitation led to a median hourly urine output of 100 ml in 19 patients who were not anuric on admission, four (21%) developed clinical pulmonary oedema subsequently. MAP was unrelated to volume responsiveness (p = 0.71), while a low JVP, dry mucous membranes, dry axillae, increased tissue turgor, prolonged capillary refill, and tachycardia all had a positive predictive value for volume responsiveness of ≤50%. Extravascular lung water ≥11 ml/kg indicating pulmonary oedema was present on 99 of the 353 times that it was assessed during the study, but was identified on less than half these occasions by tachypnoea, chest auscultation, or an elevated JVP. A clear chest on auscultation and a respiratory rate <30 breaths/minute could exclude pulmonary oedema on 82% and 72% of occasions respectively.

Conclusions

Findings on physical examination correlate poorly with true volume status in adults with severe malaria and must be used with caution to guide fluid therapy.

Trial registration

Clinicaltrials.gov identifier: NCT00692627

Keywords

Severe malaria Physical examination Fluid resuscitation

Background

After several days of fever, sweating, vomiting and, frequently, impaired consciousness, adults with severe malaria are usually dehydrated and hypovolaemic - some profoundly so [1]. As hypovolaemia evolves, the Frank-Starling principle dictates that the cardiac output will fall, reducing tissue perfusion and potentially exacerbating the metabolic acidosis and acute kidney injury (AKI) that are strong predictors of mortality [2, 3]. Although microvascular sequestration and endothelial dysfunction are central to the pathogenesis of acidosis and AKI in severe malaria [46], neither have an effective treatment [7]. Meanwhile hypovolaemia has a widely available and inexpensive remedy: fluid resuscitation.

If a patient is volume responsive, fluid loading increases stroke volume and hence cardiac output and oxygen delivery to tissues. However in severe malaria, even if rehydration improves systemic haemodynamics, there may be limited improvement in the microvascular obstruction, which makes a greater relative contribution to tissue hypoperfusion [1, 8]. Adults with severe malaria also have a generalized increase in vascular permeability which is particularly important in the lungs where pulmonary oedema can occur rapidly, unpredictably, and is frequently fatal [810]. The hazards of fluid loading have also been demonstrated recently in African children with severe malaria, with mortality substantially higher in the patients receiving liberal resuscitation than in those receiving standard maintenance therapy [11]. Finding a balance between over- and under-hydration is therefore challenging for the clinician managing severe malaria.

As patients with severe malaria will usually be managed in a resource-poor setting, World Health Organization (WHO) guidelines necessarily emphasize clinical assessment of volume status to guide rehydration [12]. These guidelines emphasize the utility of blood pressure, urine output and jugular venous pressure (JVP) in particular [12], although there are few study data to support the safety of this approach.

In order to assess the reliability of physical examination in guiding the fluid management of adults with severe malaria, data from a recent prospective study assessing fluid resuscitation of adults with severe falciparum malaria were examined. The objective was to determine the relationship between the findings on the patient’s physical examination and their volume status. Did simple clinical signs identify hypovolaemic patients and, of critical clinical relevance, did these signs identify patients who were volume responsive or at risk of pulmonary oedema?

Methods

Patients were recruited at Chittagong Medical College Hospital in Bangladesh and Ispat General Hospital in Rourkela, India in 2008. Patients were defined as having malaria if asexual forms of Plasmodium falciparum were present on blood film or, if expert microscopy was not immediately available, an immunochromatographic rapid diagnostic test (Paracheck Pf, Orchid Biomedical Systems, India) was positive. Falciparum malaria was later confirmed by examination of a simultaneously collected blood slide. As invasive haemodynamic monitoring was employed, only severely ill adult patients with malaria were enrolled. The prospectively defined severity criteria were: peripheral venous base deficit of >6 mmol/L, blood urea nitrogen >60 mg/dL (21.4 mmol/L) or clinical pulmonary oedema (defined as oxygen saturation <90% with bi-basal crepitations on respiratory examination). Patients were enrolled only after written informed consent was obtained from an accompanying relative via a local translator. Patients were excluded if they were less than 16 years of age or if they had received adequate anti-malarial treatment for more than 24 hours before enrolment.

Ethical review

The Bangladeshi Medical Research Council, the institutional ethical board of Ispat General Hospital, and the Oxford Tropical Research Ethics Committee provided ethical approval for the study. Regular safety reviews were performed by independent local committees and all deaths and serious adverse events were reported to these committees within 24 hours for appraisal.

Patient management

All patients were admitted to an intensive care unit where a detailed history was taken and a physical examination was performed. Patients received intravenous artesunate and supportive care as per treatment guidelines of the time [13]. The original study assessed the response to liberal fluid resuscitation guided by published algorithms using volumetric indices [14]. Patients received normal (0.9%) saline intravenous fluid replacement and were assessed hourly during the first six hours and then six hourly thereafter until 96 hours, the patient’s death or a patient/family request to discontinue monitoring, whichever came first. Blood was transfused if the haemoglobin concentration fell below 5 g/dL. Respiratory support, dialysis, and inotropic support were initiated based on the judgement of the attending clinicians.

Investigations

Haemodynamic investigations

Haemodynamic measurements were made using transpulmonary thermodilution and arterial pulse contour analysis (PiCCO-plus®, Pulsion, Germany). To obtain these measurements a standard triple lumen central venous catheter was inserted into the subclavian or internal jugular vein and a 5-French thermistor tipped arterial catheter (Pulsiocath, Pulsion, Germany) was inserted into the femoral artery. The physiological basis for measurement of haemodynamic variables using the PiCCO system is described in detail elsewhere [15, 16]. Briefly, chilled saline (<8 C) was injected into the central vein, and the thermistor at the tip of the femoral artery catheter measured the downstream temperature change. Cardiac output was calculated by analysis of the thermodilution curve using a modified Stewart-Hamilton algorithm. All volumetric parameters were obtained by analysis of the thermodilution curve. These parameters include global end diastolic volume (GEDVI), a measure of volume status, and extravascular lung water (ELWI). The patient’s height was entered into the PiCCO monitor that calculated the ideal body weight and indexed values. The target GEDVI was >700 ml/m2 while aiming to maintain the ELWI ≤10 ml/kg. Central venous pressure (CVP) was measured using a manometer connected to the patient and a flask of saline via a three-way tap, the level of the right atrium was designated as the zero point. Patients were defined as volume responsive if there was a greater than 15% increase in cardiac index with a fluid load of greater than 500 ml. In this study, the ELWI cut-off for pulmonary oedema was set at ≥11 ml/kg based on recent autopsy validation studies [17].

Clinical assessment

Before each invasive haemodynamic evaluation, one of two clinicians (JH and SWKL, both with over five years’ post-graduate clinical experience) performed a physical examination with a particular emphasis on the patient’s volume status. The mucous membranes were classified as normal, mildly dry, or very dry and the axillae that were classified as moist or dry. Capillary refill was assessed by applying finger pulp pressure and classified as normal (<2 seconds), prolonged (2–4 seconds) or very prolonged (>4 seconds). Tissue turgor was determined by examining the skin on the abdomen and was classified as normal or decreased. JVP was assessed with the patient at 45º and was recorded as the height above the sternal angle. It was classified as very low (absent on inspection, but filling of neck veins confirmed with compression at the base of the neck), low (1–2 cm above the sternal angle), normal (3–4 cm above the sternal angle), or elevated (≥5 cm above the sternal angle). Blood pressure and heart rate were recorded from the intra-arterial catheter. Respiratory rate was counted at the bedside for 30 seconds. The lungs were auscultated and crepitations were classified as absent, mild (lower third) moderate (lower 2/3) or severe (entire lung field).

Statistical analysis

Data were collected and entered into an anonymized database and analysed using statistical software (Stata version 10, StataCorp). Correlation coefficients were determined using Spearman’s method. Groups were analysed using the Kruskal-Wallis test. Multivariate linear regression was used to determine the relative contributions of explanatory variables when more than one was significant in univariate analysis.

Results

Twenty eight patients were enrolled and 23 survived to discharge. All patients were hypovolaemic on enrolment: GEDVI (median 481 ml/m2, range 346–675 ml/m2, normal 680–800 ml/m2). Two patients had clinical pulmonary oedema on enrolment and so did not receive liberal fluid resuscitation. Of the remaining 26 patients, 23 (88%) had a severe metabolic acidosis while nine (35%) satisfied the AKI criterion. The 26 patients that were resuscitated received 81 fluid boluses of greater than 500 ml (a median of three per patient) without concurrent inotropes during their hospitalization. The cardiac output was volume responsive on 23 of these 81 occasions. Eight of the 26 patients developed clinical pulmonary oedema during their hospital stay.

Assessment of hypovolaemia and fluid responsiveness

Jugular venous pressure

The JVP correlated with the invasively measured CVP, on admission (rs = 0.45, p = 0.02) and the 367 times both were assessed simultaneously (rs = 0.43, p < 0.001) over the course of the study. However the JVP did not correlate significantly with the intravascular volume (as determined by the GEDVI) on either admission (rs = 0.32, p = 0.11) nor on the 367 times they were measured concurrently (rs = 0.07, p = 0.19). Mean GEDVI was similar in the patients with a very low JVP and those with an elevated JVP (Table 1). There was no relationship between JVP and cardiac index (CI) on admission (rs = 0.04, p = 0.85), nor on the 363 times they were concurrently measured in the absence of inotropic support (rs = 0.03, p = 0.85). The JVP performed poorly in identifying on which of these occasions patients would be fluid responsive: a low JVP had a positive predictive value (PPV) of 42% (95% confidence intervals (CI): 23-63%), while a very low JVP had a PPV of 40% (95% CI: 14-68%).
Table 1

Correlation between jugular venous pressure and invasive haemodynamic measures

 

Number of observations

GEDVI

CI2

ELWI3

 

mean (95% CI)1

mean (95% CI)

mean (95% CI)

Very low JVP 4

68

566 (535 – 598)

3.39 (3.24 – 3.54)

10.5 (9.4 – 11.6)

Low JVP 5

50

519 (497–540)

3.38 (3.21 – 3.55)

9.6 (8.9 – 10.2)

Normal JVP 6

74

599 (570 – 629)

3.58 (3.42 – 3.75)

9.0 (8.5 – 9.5)

Elevated JVP 7

175

570 (553–588)

3.46 (3.36 – 3.57)

9.4 (9.0 – 9.8)

1 Global end diastolic volume index (normal range 680–800 ml/m2).

2 Cardiac index (normal range 2.5-4.0 L/min/m2).

3 Extravascular Lung Water Index (normal range 3-7 ml/kg).

4 Not visible with the patient at 45º.

5 1 to 2 cm above the sternal angle with the patient at 45º.

6 3 to 4 cm above the sternal angle with the patient at 45º.

7 ≥5 cm above the sternal angle with the patient at 45º.

Blood pressure

On enrolment, mean (95% CI) MAP was lower in survivors than in the patients who would later die (86 mmHg (79–95) versus 98 mmHg (90–109)), although this was of borderline statistical significance (p = 0.051). MAP was weakly correlated with intravascular volume (rs = 0.16, p = 0.002), but even in patients with significant hypovolaemia, blood pressure was usually preserved: the mean (95% CI) MAP in patients with a GEDVI <500 ml/m2 was 87 mmHg (84–91). MAP did not predict volume responsiveness: the mean (95% CI) MAP in volume responsive patients was 89 mmHg (82–96) versus 88 mmHg (83–92) in those that were not.

Urine output

Eight patients were anuric on admission. There was no significant difference in the mean (95% CI) GEDVI between anuric patients (516 ml/m2 (424–608)) and those passing urine (486 ml/m2 (443–529) (p = 0.58)). Six of these eight patients required renal replacement therapy (RRT), the remaining two were managed without RRT, but neither regained a urine output with fluid resuscitation. Nineteen of the 20 remaining patients were fluid resuscitated (one was in pulmonary oedema on admission) and received a median of 3.6 L in the first six hours of their hospitalization. These 19 patients had a median hourly urine output of 100 ml/hour although four subsequently developed clinical pulmonary oedema, two of whom also developed anuria in the setting of multi-organ dysfunction.

Other signs of hypovolaemia

Other clinical indices performed poorly in identifying hypovolaemia and predicting volume responsiveness (Tables 2, 3 and 4). Prolonged capillary refill and decreased tissue turgor occurred infrequently (7 and 4% of assessments, respectively). Patients with poor capillary return had a significantly lower intravascular volume; however patients with decreased tissue turgor actually had a significantly higher intravascular volume. Meanwhile dry axillae and dry mucous membranes were neither sensitive nor specific for hypovolaemia. Heart rate correlated weakly with volume status (rs = −0.16, p = 0.002); tachycardic patients were usually hypovolaemic and heart rate fell as patients were fluid loaded early in their hospitalization. However, temperature was also elevated during this period and was also correlated with heart rate (rs = 0.32, p < 0.001); while both hypovolaemia and temperature correlated with heart rate on multivariate analysis, temperature had the stronger association.
Table 2

Ability of clinical signs to identify hypovolaemia in adults with severe malaria

Clinical finding

Hypovolaemic1

Euvolaemic1

PPV

NPV

Sensitivity

Specificity

   

(95% CI)

(95% CI)

(95% CI)

(95% CI)

Dry mucous membranes

235/324

42/65

85%

21%

73%

35%

(80–89)

(14–29)

(68–78)

(24–48)

Dry axillae

138/324

27/65

84%

17%

43%

58%

(77–89)

(12–23)

(37–48)

(46–71)

Decreased tissue turgor

12/324

7/65

63%

16%

4%

89%

(38–84)

(12–20)

(2–6)

(79–96)

Prolonged capillary refill 2,3

28/307

1/53

97%

16%

9%

98%

(82–100)

(12–20)

(6–13)

(90–100)

Tachycardia > 100 bpm3

127/308

16/53

89%

17%

41%

70%

(82–93)

(12–23)

(36–47)

(56–82)

Tachycardia > 120 bpm3

28/308

2/53

93%

15%

9%

96%

(78–99)

(12–20)

(6–13)

(87–100)

Low JVP4

101/303

18/64

85%

18%

33%

72%

(77–91)

(14–24)

(28–39)

(59–82)

PPV Positive predictive value, NPV Negative predictive value.

1 Hypovolaemic: global end diastolic volume index (GEDVI) <680 ml/m2, euvolaemic: GEDVI: 680–800 ml/m2.

2 Greater than 2 seconds.

3 Excluding patients receiving inotropic support.

4 JVP < 3-4 cm above the sternal angle with the patient at 45º.

Table 3

Correlation between clinical signs of hypovolaemia and invasive haemodynamic measures

  

Number of observations

GEDVI1

CI2

ELWI3

  

mean (95% CI)

mean (95% CI)

mean (95% CI)

Mucous membranes

Normal

132

572 (548 – 595)

3.57 (3.43 – 3.71)

9.6 (8.9 – 10.3)

Dry

297

562 (548 – 576)

3.42 (3.34 – 3.51)

9.8 (9.4 – 10.1)

Axillae

Moist

253

571 (556–585)

3.47 (3.38 -3.57)

9.4 (9.0 -9.8)

Dry

177

556 (536–576)

3.46 (3.35 – 3.56)

10.1 (9.6 -10.7)

Tissue turgor

Normal

409

560 (548 – 573)

3.5 (3.43 - 3.57)

9.7 (9.3- 10.0)

Decreased

21

643 (602 – 684)ɸ

2.83 (2.59 - 3.07) ɸ

10.8 (9.3 – 12.2)

Capillary return*

Normal

371

566 (554–579)

3.52 (3.45 -3.59)

9.5 (9.2 – 9.9)

Reduced

30

504 (473–534) ɸ

2.84 (2.54 -3.14) ɸ

9.9 (8.4 – 11.5)

Heart rate*

<100 bpm

269

575 (560 – 590)

3.43 (3.36 – 3.51)

9.3 (8.8 - 9.7)

≥100 bpm

150

543 (524 – 562) ɸ

3.51 (3.38 – 3.65)

10.0 (9.5 – 10.5) ɸ

Heart rate*

<120 bpm

387

565 (552 – 578)

3.48 (3.41 – 3.55)

9.4 (9.1 – 9.7)

≥120 bpm

32

528 (497 – 560)

3.3 (2.93 - 3.66)Ʊ

11.4 (10.2 - 12.7) ɸ

1 Global end-diastolic volume index.

2 Cardiac index.

3 Extravascular lung water index.

* In the absence of inotropic therapy.

ɸ p < 0.01 for a difference.

Ʊ p < 0.05 for a difference.

Table 4

Ability of clinical signs to identify volume responsiveness in adults with severe malaria (Includes only those patients receiving a fluid bolus of >500 ml in the absence of inotropic support)

Clinical finding

Volume responsive

Not volume responsive

PPV

NPV

Sensitivity

Specificity

(95% CI)

(95% CI)

(95% CI)

(95% CI)

Dry mucous membranes

19/23

44/58

30% (19–43)

78% (52–94)

83% (61–95)

24% (14–37)

Dry axillae

9/23

29/58

24% (11–40)

67% (51–81)

39% (20–61)

50% (37–63)

Decreased tissue turgor

2/23

2/58

50% (7–93)

73% (61–82)

9% (1–28)

97% (88–100)

Prolonged capillary refill 1*

4/23

12/57

25% (7–52)

70% (58–81)

17% (5–39)

79% (66–89)

Tachycardia > 100 bpm

11/23

29/58

28% (15–44)

71% (54–84)

48% (27–69)

50% (37–63)

Tachycardia > 120 bpm

0/23

3/58

0% (0–77)

71% (59–80)

0% (0–15)

95% (86–99)

Low JVP2*

11/23

15/57

42% (23–63)

78% (64–88)

48% (27–69)

74% (60–85)

Very low JVP3*

6/23

9/57

40% (16–68)

74% (61–84)

26% (10–48)

84% (72–93)

1 Greater than 2 seconds.

2 Low JVP: < 3–4 cm above the sternal angle with the patient at 45º.

3 Very low JVP: invisible at rest with the patient at 45º, jugular vein fills with base of neck compression.

* In one patient the JVP was not visible and in one the capillary refill was not recorded.

Identification of pulmonary oedema

Lung water correlated with respiratory function as determined by the SaO2:FiO2 ratio (rs = −0.24, p < 0.0001). A SaO2:FiO2 ratio was available on 87 of the 99 occasions when ELWI was ≥ 11 ml/kg (poor peripheral circulation precluded a reliable oximetry reading in the remaining cases). On 58 (67%) of these 87 occasions respiratory function was significantly impaired (SaO2:FiO2 ratio <450).

The JVP did not correlate with the lung water either on admission (rs = −0.06, p = 0.77) or on the 367 times they were measured concurrently (rs = −0.05, p = 0.31). An elevated and very low JVP had a similar PPV for pulmonary oedema (when defined as an ELWI of ≥11 ml/kg, normal range 3-7 ml/kg) (Table 1). The JVP did not correlate with respiratory function (as determined by SaO2:FiO2 ratio) either on admission (rs = −0.19, p = 0.34) or on the 362 times they were measured concurrently (rs = −0.08, p = 0.14). Two patients had clinical pulmonary oedema (bibasal crepitations and oxygen saturation <90%, in addition to elevated ELWI) on admission; one had a normal JVP, while the other had a low JVP. Eight other patients developed clinical pulmonary oedema during the study, at the time pulmonary oedema developed four of these patients had an elevated JVP, two had a normal JVP and in two the JVP was not discernible. A respiratory rate of less than 30 and the absence of crepitations on auscultation were moderately specific in excluding pulmonary oedema, however no clinical sign had a good PPV for the condition (Table 5).
Table 5

Ability of clinical signs to identify pulmonary oedema in adults with severe malaria

Clinical finding

Pulmonary oedema*

No pulmonary oedema

PPV

NPV

Sensitivity

Specificity

(95% CI)

(95% CI)

(95% CI)

(95% CI)

Crepitations on auscultation

30/99

46/254

39% (28–51)

75% (70–80)

39% (21–40)

82% (77–86)

Tachypnoea >20 breaths/min

81/98

221/250

27% (22–32)

63% (48–77)

83% (74–90)

12% (8–16)

Tachypnoea >30 breaths/min

38/98

71/250

35% (26–45)

75% (69–80)

39% (29–49)

72% (66–77)

Elevated JVP1#

47/92

121/247

28% (21–35)

74% (66–80)

51% (40–62)

51% (45–57)

Low JVP2#

31/92

69/247

31% (22–41)

74% (68–80)

34% (24–44)

72% (66–78)

PPV Positive predictive value, NPV Negative predictive value.

* Extravascular lung water index ≥ 11 ml/kg (patients with concomitant aspiration pneumonia excluded).

1 JVP ≥5 cm above the sternal angle with the patient at 45º.

2 JVP < 3–4 cm above the sternal angle with the patient at 45º.

# JVP not visible in all patients.

Discussion

Optimization of volume status is central to the management of all critically ill populations. It is challenging in well-resourced critical care settings, let alone on general wards in the rural tropics where most adults with severe malaria will be managed. While current WHO management guidelines necessarily emphasize bedside evaluation of volume status, in this prospective study of adults with severe falciparum malaria physical examination failed to identify volume-responsive patients or those at risk of pulmonary oedema reliably. Despite few alternatives in the resource-poor setting, clinicians managing patients with severe malaria must be cautious using the physical examination to guide fluid resuscitation.

All patients in this series were hypovolaemic on enrolment and, with almost 90% having severe metabolic acidosis and over a third with significant AKI, these patients represented the population most likely to benefit from rehydration. However, it is not enough to simply “fill a patient up”; fluid resuscitation should produce a demonstrable enhancement of tissue perfusion. If clinicians are to prescribe more than maintenance fluid to an adult with severe malaria they must answer two fundamental questions: is the patient volume responsive and does the patient have incipient pulmonary oedema? These data suggest that the physical examination has a limited ability to identify either population reliably.

Clinical features of severe malaria vitiate the interpretation of many of the signs of hypovolaemia. Fever, tachypnoea and anaemia may lead to tachycardia; respiratory compensation for a metabolic acidosis may lead to dry mucous membranes; malaria-associated kidney injury may lead to oliguria; while cerebral malaria complicates assessment of cerebral perfusion and precludes the assessment of postural changes in patients’ haemodynamics.

The JVP, the clinical surrogate of the invasively measured CVP, is particularly highlighted in the WHO guidelines as a guide to intravascular volume, despite it being a notoriously difficult sign for even experienced clinicians to interpret [12, 18]. More relevantly, there is a growing consensus that the CVP has a limited role in guiding fluid resuscitation in critically ill patients [19] and certainly in patients with malaria, there is little correlation between CVP and clinical endpoints, such as acidosis or pulmonary oedema [2023]. One possibility is that the extensive myocardial sequestration seen at autopsy [24] leads to reduced ventricular compliance which would explain the disparity between the volumetric (such as the GEDVI) and pressure-based indices (such as the JVP and CVP). However, whatever the mechanism, these data suggest that relying on the JVP to identify patients who are volume responsive or at risk of pulmonary oedema is unhelpful at best and may be harmful. Other physical signs were not much more useful. Abnormal capillary refill and decreased tissue turgor occurred rarely in this series, highlighting the limited utility of these two clinical signs in adults [25, 26]. Indeed paradoxically, the intravascular volume of patients with decreased tissue turgor was significantly higher than patients with normal tissue turgor. Dry axillae and dry mucous membranes were present more frequently but were non-specific findings.

Blood pressure is also a suggested resuscitation endpoint in the current WHO malaria treatment guidelines [12] and is widely used to guide fluid replacement in critically ill patients. Liberal fluid resuscitation with a target MAP of ≥65 mmHg is part of the Surviving Sepsis Guidelines bundle of care, which has led to an impressive improvement in outcomes [27, 28]. Even in a resource-poor setting, prompt fluid loading reduces case fatality rates in dengue shock syndrome (DSS) to <0.2% [29]. However, unlike severe sepsis and DSS, hypotension is relatively uncommon in falciparum malaria; indeed, in large studies, patients with higher blood pressure on admission to hospital are more likely to die [30]. In this series hypotension was rare and generally occurred in the setting of severe multi-organ dysfunction at which time it was usually unresponsive to fluids or inotropes. In adults with falciparum malaria the elevation in blood pressure and the systemic vascular resistance are correlated with the amount of sequestration of parasitized erythrocytes in the microvasculature [1]. Sequestration could elevate blood pressure directly via microvascular obstruction or, more likely, indirectly by leading to endothelial dysfunction and loss of vasodilatory tone [31]. The haemolysis seen in malaria results in the release of free haemoglobin leading to nitric oxide quenching which may exacerbate this endothelial dysfunction [32].

Fluid resuscitation and anti-malarial therapy are central to the treatment of AKI, a life-threatening condition which occurs in almost half of adults with severe malaria [33]. Current WHO guidelines focus appropriately on urine output as a bedside measure of renal function, although the suggested resuscitation target of 1 ml/kg/hour is greater than is used in most other settings [12, 34, 35] and is problematic given the lower threshold for complications seen with fluid loading in malaria. In this study the median hourly urine output of 100 ml/hour was not very much greater than the WHO recommended figure and yet to achieve this urine output patients received very generous fluid resuscitation and over 20% developed clinical pulmonary oedema. Microvascular sequestration is prominent in patients dying with AKI and this process is relatively unaffected by even liberal fluid loading [5, 8]. Thus, while it may be appropriate to administer small boluses in an attempt to correct oliguria, in cases that fail to respond early referral for renal replacement therapy should be considered given the harm that may result from continuing to unsuccessfully fluid-challenge a patient.

As pulmonary oedema in patients with severe malaria results from increased pulmonary vascular permeability, it may not be surprising that clinical signs of volume status have limited utility in its identification [36]; in this study all patients were hypovolaemic or euvolaemic (as assessed by GEDVI) at the time they developed clinical pulmonary oedema. The JVP’s ability to confirm or exclude pulmonary oedema was notably poor, although an absence of tachypnoea or crepitations on chest auscultation were more helpful in ruling the condition out.

With the physical examination’s shortcomings in defining volume status in this and other settings [3741], what is the clinician to do? It is clearly not possible to dispense with the physical examination which remains essential in identifying disease complications and concomitant pathology [42]. Individual clinical signs of hypovolaemia may be more useful when considered collectively and cumulatively and evaluated in the context of available laboratory and radiological investigations [43, 44]. However these data suggest that the physical signs of volume status need to be interpreted with caution and that fluid resuscitation is potentially dangerous even in adult patients with severe falciparum malaria who are “clinically” hypovolaemic.

The study has limitations. A relatively small number of patients were studied and the strict inclusion criteria enrolled only the most critically ill patients, the findings may not be generalizable, particularly to patients with less severe disease. Two clinicians performed the physical examination, but only one performed the examination on each occasion, potentially introducing inter-observer variability into the analysis. Except for the assessment on enrolment, the clinicians were aware of the patient’s prior progress and this may have influenced their examination, although it might be expected that this would have improved the performance of the clinical findings. The gold standard for hypovolaemia and pulmonary oedema were volumetric indices derived from transpulmonary thermodilution. Whilst this method is used widely in different critical care populations it has not been specifically validated in patients with severe malaria. Only adult patients were studied, although series of African children with severe malaria have also identified limitations of traditional bedside tests of volume status [45, 46].

Conclusions

The majority of deaths in patients with severe malaria will occur within 48 hours of their admission to hospital; to reduce mortality supportive care must be improved during this critical period. Most patients are hypovolaemic on admission and any fluid deficit will need to be replaced in time, but these data suggest that clinical examination is a poor predictor of the patient’s volume status and fluid resuscitation should proceed cautiously, even in patients who are clinically hypovolaemic.

Declarations

Acknowledgements

Professor Nick Anstey, Dr David Bihari and Dr Prakaykaew Charunwatthana provided support and advice during preparation of the study and the manuscript.

Authors’ Affiliations

(1)
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University
(2)
Menzies School of Health Research, Darwin, Northern Territory
(3)
Chittagong Medical College Hospital
(4)
Ispat General Hospital
(5)
Academic Medical Center, University of Amsterdam
(6)
Nuffield Department of Medicine, Centre for Tropical Medicine, University of Oxford

References

  1. Hanson J, Lam SW, Mahanta KC, Pattnaik R, Alam S, Mohanty S, Hasan MU, Hossain A, Charunwatthana P, Chotivanich K, Maude RJ, Kingston H, Day NP, Mishra S, White NJ, Dondorp AM: Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria. J Infect Dis. 2012, 206: 571-579. 10.1093/infdis/jis400.View ArticlePubMedGoogle Scholar
  2. Hanson J, Lee SJ, Mohanty S, Faiz MA, Anstey NM, Charunwatthana P, Yunus EB, Mishra SK, Tjitra E, Price RN, Rahman R, Nosten F, Htut Y, Hoque G, Hong Chau TT, Hoan Phu N, Hien TT, White NJ, Day NP, Dondorp AM: A simple score to predict the outcome of severe malaria in adults. Clin Infect Dis. 2010, 50: 679-685. 10.1086/649928.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Day NP, Phu NH, Mai NT, Chau TT, Loc PP, Chuong LV, Sinh DX, Holloway P, Hien TT, White NJ: The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med. 2000, 28: 1833-1840. 10.1097/00003246-200006000-00025.View ArticlePubMedGoogle Scholar
  4. Dondorp AM, Ince C, Charunwatthana P, Hanson J, van Kuijen A, Faiz MA, Rahman MR, Hasan M, Bin Yunus E, Ghose A, Ruangveerayut R, Limmathurotsakul D, Mathura K, White NJ, Day NP: Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis. 2008, 197: 79-84. 10.1086/523762.View ArticlePubMedGoogle Scholar
  5. Nguansangiam S, Day NP, Hien TT, Mai NT, Chaisri U, Riganti M, Dondorp AM, Lee SJ, Phu NH, Turner GD, White NJ, Ferguson DJ, Pongponratn E: A quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria. Trop Med Int Health. 2007, 12: 1037-1050. 10.1111/j.1365-3156.2007.01881.x.View ArticlePubMedGoogle Scholar
  6. Yeo TW, Lampah DA, Tjitra E, Gitawati R, Darcy CJ, Jones C, Kenangalem E, McNeil YR, Granger DL, Lopansri BK, Weinberg JB, Price RN, Duffull SB, Celermajer DS, Anstey NM: Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog. 2010, 6: e1000868-10.1371/journal.ppat.1000868.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Krishna S: Adjunctive management of malaria. Curr Opin Infect Dis. 2012, 25: 484-488. 10.1097/QCO.0b013e3283567b20.View ArticlePubMedGoogle Scholar
  8. Hanson JP, Lam SW, Mohanty S, Alam S, Pattnaik R, Mahanta KC, Hasan MU, Charunwatthana P, Mishra SK, Day NP, White NJ, Dondorp AM: Fluid resuscitation of adults with severe falciparum malaria: effects on acid–base status, renal function, and extravascular lung water. Crit Care Med. 2013, 41: 972-981. 10.1097/CCM.0b013e31827466d2.View ArticlePubMedGoogle Scholar
  9. Krishnan A, Karnad DR: Severe falciparum malaria: an important cause of multiple organ failure in Indian intensive care unit patients. Crit Care Med. 2003, 31: 2278-2284. 10.1097/01.CCM.0000079603.82822.69.View ArticlePubMedGoogle Scholar
  10. Davis TM, Suputtamongkol Y, Spencer JL, Ford S, Chienkul N, Schulenburg WE, White NJ: Measures of capillary permeability in acute falciparum malaria: relation to severity of infection and treatment. Clin Infect Dis. 1992, 15: 256-266. 10.1093/clinids/15.2.256.View ArticlePubMedGoogle Scholar
  11. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM, FEAST Trial Group: Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011, 364: 2483-2495. 10.1056/NEJMoa1101549.View ArticlePubMedGoogle Scholar
  12. WHO: Management of Severe Malaria: a practical handbook 2012. 2012, Geneva: World Health OrganizationGoogle Scholar
  13. WHO: Guidelines for the treatment of malaria 2006. 2006, Geneva: World Health OrganizationGoogle Scholar
  14. PiCCO treatment algorithm. 2008, Pulsion Medical Systems,http://www.pulsion.com/fileadmin/pulsion_share/Products_Flyer/PiCCO_decisiontree_EN_PC81607_R08_131008.pdf,
  15. Godje O, Hoke K, Goetz AE, Felbinger TW, Reuter DA, Reichart B, Friedl R, Hannekum A, Pfeiffer UJ: Reliability of a new algorithm for continuous cardiac output determination by pulse-contour analysis during hemodynamic instability. Crit Care Med. 2002, 30: 52-58. 10.1097/00003246-200201000-00008.View ArticlePubMedGoogle Scholar
  16. Litton E, Morgan M: The PiCCO monitor: a review. Anaesth Intensive Care. 2012, 40: 393-409.PubMedGoogle Scholar
  17. Tagami T, Kushimoto S, Yamamoto Y, Atsumi T, Tosa R, Matsuda K, Oyama R, Kawaguchi T, Masuno T, Hirama H, Yokata H: Validation of extravascular lung water measurement by single transpulmonary thermodilution: human autopsy study. Crit Care. 2010, 14: R162-10.1186/cc9250.PubMed CentralView ArticlePubMedGoogle Scholar
  18. McGee SR: Physical examination of venous pressure: a critical review. Am Heart J. 1998, 136: 10-18. 10.1016/S0002-8703(98)70175-9.View ArticlePubMedGoogle Scholar
  19. Marik PE, Cavallazzi R: Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense*. Crit Care Med. 2013, 41: 1774-1781. 10.1097/CCM.0b013e31828a25fd.View ArticlePubMedGoogle Scholar
  20. Hanson J, Lam SW, Mohanty S, Alam S, Hasan MM, Lee SJ, Schultz MJ, Charunwatthana P, Cohen S, Kabir , Mishra S, Day NP, White NJ, Dondorp AM: Central venous catheter use in severe malaria: time to reconsider the World Health Organization guidelines?. Malar J. 2011, 10: 342-10.1186/1475-2875-10-342.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Nguyen HP, Hanson J, Bethell D, Nguyen TH, Tran TH, Ly VC, Pham PL, Dinh XS, Dondorp A, White N, Tran TH, Day N: A retrospective analysis of the haemodynamic and metabolic effects of fluid resuscitation in Vietnamese adults with severe falciparum malaria. PLoS One. 2011, 6: e25523-10.1371/journal.pone.0025523.View ArticlePubMedGoogle Scholar
  22. Aursudkij B, Wilairatana P, Vannaphan S, Walsh DS, Gordeux VR, Looareesuwan S: Pulmonary edema in cerebral malaria patients in Thailand. Southeast Asian J Trop Med Public Health. 1998, 29: 541-545.PubMedGoogle Scholar
  23. Brooks MH, Kiel FW, Sheehy TW, Barry KG: Acute pulmonary edema in falciparum malaria. N Engl J Med. 1968, 279: 732-737. 10.1056/NEJM196810032791402.View ArticleGoogle Scholar
  24. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA: Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol. 1985, 119: 385-401.PubMed CentralPubMedGoogle Scholar
  25. Vivanti A, Harvey K, Ash S, Battistutta D: Clinical assessment of dehydration in older people admitted to hospital: what are the strongest indicators?. Arch Gerontol Geriatr. 2008, 47: 340-355. 10.1016/j.archger.2007.08.016.View ArticlePubMedGoogle Scholar
  26. Schriger DL, Baraff LJ: Capillary refill–is it a useful predictor of hypovolemic states?. Ann Emerg Med. 1991, 20: 601-605. 10.1016/S0196-0644(05)82375-3.View ArticlePubMedGoogle Scholar
  27. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.View ArticlePubMedGoogle Scholar
  28. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013, 41: 580-637. 10.1097/CCM.0b013e31827e83af.View ArticlePubMedGoogle Scholar
  29. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, Tran VD, Nguyen TH, Nguyen VC, Stepniewska K, White NJ, Farrar JJ: Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005, 353: 877-889. 10.1056/NEJMoa044057.View ArticlePubMedGoogle Scholar
  30. Newton PN, Stepniewska K, Dondorp A, Silamut K, Chierakul W, Krishna S, Davis TM, Suputtamongkol Y, Angus B, Pukrittayakamee S, Ruangveerayuth R, Hanson J, Day NP, White NJ: Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand. Malar J. 2013, 12: 229-10.1186/1475-2875-12-229.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM: Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med. 2007, 204: 2693-2704. 10.1084/jem.20070819.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Yeo TW, Lampah DA, Tjitra E, Gitawati R, Kenangalem E, Piera K, Granger DL, Lopansri BK, Weinberg JB, Price RN, Duffull SB, Celermajer DS, Anstey NM: Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis. 2009, 200: 1522-1529. 10.1086/644641.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Das BS: Renal failure in malaria. J Vector Borne Dis. 2008, 45: 83-97.PubMedGoogle Scholar
  34. Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet. 2005, 365: 417-430.View ArticlePubMedGoogle Scholar
  35. Jansen JO, Cuthbertson BH: Detecting critical illness outside the ICU: the role of track and trigger systems. Curr Opin Crit Care. 2010, 16: 184-190. 10.1097/MCC.0b013e328338844e.View ArticlePubMedGoogle Scholar
  36. Taylor WR, Hanson J, Turner GD, White NJ, Dondorp AM: Respiratory manifestations of malaria. Chest. 2012, 142: 492-505. 10.1378/chest.11-2655.View ArticlePubMedGoogle Scholar
  37. McGee S, Abernethy WB, Simel DL: The rational clinical examination. Is this patient hypovolemic?. Jama. 1999, 281: 1022-1029. 10.1001/jama.281.11.1022.View ArticlePubMedGoogle Scholar
  38. McGarvey J, Thompson J, Hanna C, Noakes TD, Stewart J, Speedy D: Sensitivity and specificity of clinical signs for assessment of dehydration in endurance athletes. Br J Sports Med. 2010, 44: 716-719. 10.1136/bjsm.2008.053249.View ArticlePubMedGoogle Scholar
  39. Saugel B, Ringmaier S, Holzapfel K, Schuster T, Phillip V, Schmid RM, Huber W: Physical examination, central venous pressure, and chest radiography for the prediction of transpulmonary thermodilution-derived hemodynamic parameters in critically ill patients: a prospective trial. J Crit Care. 2011, 26: 402-410. 10.1016/j.jcrc.2010.11.001.View ArticlePubMedGoogle Scholar
  40. Benbassat J, Baumal R: Narrative review: should teaching of the respiratory physical examination be restricted only to signs with proven reliability and validity?. J Gen Intern Med. 2010, 25: 865-872. 10.1007/s11606-010-1327-8.PubMed CentralView ArticlePubMedGoogle Scholar
  41. Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT: Does this dyspneic patient in the emergency department have congestive heart failure?. Jama. 2005, 294: 1944-1956. 10.1001/jama.294.15.1944.View ArticlePubMedGoogle Scholar
  42. Joshua AM, Celermajer DS, Stockler MR: Beauty is in the eye of the examiner: reaching agreement about physical signs and their value. Intern Med J. 2005, 35: 178-187. 10.1111/j.1445-5994.2004.00795.x.View ArticlePubMedGoogle Scholar
  43. Sinert R, Spektor M: Evidence-based emergency medicine/rational clinical examination abstract. Clinical assessment of hypovolemia. Ann Emerg Med. 2005, 45: 327-329. 10.1016/j.annemergmed.2004.09.021.View ArticlePubMedGoogle Scholar
  44. Marik PE: Assessment of intravascular volume: a comedy of errors. Crit Care Med. 2001, 29: 1635-1636. 10.1097/00003246-200108000-00024.View ArticlePubMedGoogle Scholar
  45. Pamba A, Maitland K: Capillary refill: prognostic value in Kenyan children. Arch Dis Child. 2004, 89: 950-955. 10.1136/adc.2003.032516.PubMed CentralView ArticlePubMedGoogle Scholar
  46. Maitland K, Levin M, English M, Mithwani S, Peshu N, Marsh K, Newton CR: Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. Qjm. 2003, 96: 427-434. 10.1093/qjmed/hcg077.View ArticlePubMedGoogle Scholar

Copyright

© Hanson et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement